Fine specificity and cross-clade reactivity of HIV type 1 gag-specific CD4+ T cells

Despite growing evidence that HIV-1-specific CD4(+) T helper (Th) cells may play a role in the control of viremia, discrete Th cell epitopes remain poorly defined. Furthermore, it is not known whether Th cell responses generated using vaccines based on clade B virus sequences will elicit immune resp...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:AIDS research and human retroviruses 2004-03, Vol.20 (3), p.315-325
Hauptverfasser: NORRIS, Philip J, MOFFETT, Howell F, BRANDER, Christian, ALLEN, Todd M, O'SULLIVAN, Kristin M, COSIMI, Lisa A, KAUFMANN, Daniel E, WALKER, Bruce D, ROSENBERG, Eric S
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 325
container_issue 3
container_start_page 315
container_title AIDS research and human retroviruses
container_volume 20
creator NORRIS, Philip J
MOFFETT, Howell F
BRANDER, Christian
ALLEN, Todd M
O'SULLIVAN, Kristin M
COSIMI, Lisa A
KAUFMANN, Daniel E
WALKER, Bruce D
ROSENBERG, Eric S
description Despite growing evidence that HIV-1-specific CD4(+) T helper (Th) cells may play a role in the control of viremia, discrete Th cell epitopes remain poorly defined. Furthermore, it is not known whether Th cell responses generated using vaccines based on clade B virus sequences will elicit immune responses that are effective in regions of the world where non-clade B viruses predominate. To address these issues we isolated CD4(+) T cell clones from individuals with vigorous HIV-1-specific Th cell responses and identified the minimum epitopes recognized. The minimum peptide length required for induction of CD4(+) T cell proliferation, IFN-gamma secretion, and cytolytic activity ranged from 9 to 16 amino acids in the five epitopes studied. Cross-clade recognition of the defined epitopes was examined for variant peptides from clades A, B, C, D, and AE. Over half the variant epitopes (17 of 32) exhibited impaired recognition, defined as less than 50% of the IFN-gamma secretion elicited by B clade consensus sequence. There was no evidence for antagonistic activity mediated by the variant peptides, and despite strong responses there was no escape of autologous virus from Th responses in the epitopes we studied. Abrogated recognition of variant CD4(+) T cell epitopes presents a potential obstacle to vaccine development.
doi_str_mv 10.1089/088922204322996554
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71879751</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71879751</sourcerecordid><originalsourceid>FETCH-LOGICAL-c373t-3f4c5019309892cb55356596e06db421c484169507fc7c1f9b6537ce6fececc93</originalsourceid><addsrcrecordid>eNplkDFPwzAUhC0EoqXwBxiQF1hQwI797HhEhVKkSgwU1sh5saugNClxitR_T0KDQGJ6w_vudHeEnHN2w1liblmSmDiOmRRxbIwCkAdkzI3gUSIZHJJxD0QdYUbkJIR3xljHwzEZceBcS4AxeZkVlaNh47DwBRbtjtoqp9jUIURY2tzRxllsi8_-VXs6f3qj7W7jKKcru4p-hHR6L6_pkqIry3BKjrwtgzsb7oS8zh6W03m0eH58mt4tIhRatJHwEoF1eZnpemAGIECBUY6pPJMxR5lIrgww7VEj9yZTIDQ65R06RCMm5Grvu2nqj60LbbouQp_AVq7ehlTzRBsNvAPjPfjdq3E-3TTF2ja7lLO0nzL9P2Unuhjct9na5b-SYbsOuBwAG9CWvrEVFuEPpzgDZsQX7154zQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71879751</pqid></control><display><type>article</type><title>Fine specificity and cross-clade reactivity of HIV type 1 gag-specific CD4+ T cells</title><source>Mary Ann Liebert Online Subscription</source><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>NORRIS, Philip J ; MOFFETT, Howell F ; BRANDER, Christian ; ALLEN, Todd M ; O'SULLIVAN, Kristin M ; COSIMI, Lisa A ; KAUFMANN, Daniel E ; WALKER, Bruce D ; ROSENBERG, Eric S</creator><creatorcontrib>NORRIS, Philip J ; MOFFETT, Howell F ; BRANDER, Christian ; ALLEN, Todd M ; O'SULLIVAN, Kristin M ; COSIMI, Lisa A ; KAUFMANN, Daniel E ; WALKER, Bruce D ; ROSENBERG, Eric S</creatorcontrib><description>Despite growing evidence that HIV-1-specific CD4(+) T helper (Th) cells may play a role in the control of viremia, discrete Th cell epitopes remain poorly defined. Furthermore, it is not known whether Th cell responses generated using vaccines based on clade B virus sequences will elicit immune responses that are effective in regions of the world where non-clade B viruses predominate. To address these issues we isolated CD4(+) T cell clones from individuals with vigorous HIV-1-specific Th cell responses and identified the minimum epitopes recognized. The minimum peptide length required for induction of CD4(+) T cell proliferation, IFN-gamma secretion, and cytolytic activity ranged from 9 to 16 amino acids in the five epitopes studied. Cross-clade recognition of the defined epitopes was examined for variant peptides from clades A, B, C, D, and AE. Over half the variant epitopes (17 of 32) exhibited impaired recognition, defined as less than 50% of the IFN-gamma secretion elicited by B clade consensus sequence. There was no evidence for antagonistic activity mediated by the variant peptides, and despite strong responses there was no escape of autologous virus from Th responses in the epitopes we studied. Abrogated recognition of variant CD4(+) T cell epitopes presents a potential obstacle to vaccine development.</description><identifier>ISSN: 0889-2229</identifier><identifier>EISSN: 1931-8405</identifier><identifier>DOI: 10.1089/088922204322996554</identifier><identifier>PMID: 15117455</identifier><identifier>CODEN: ARHRE7</identifier><language>eng</language><publisher>Larchmont, NY: Liebert</publisher><subject>AIDS/HIV ; Amino Acid Sequence ; Biological and medical sciences ; CD4-Positive T-Lymphocytes - immunology ; Clone Cells ; Cross Reactions ; Epitope Mapping ; Epitopes, T-Lymphocyte - chemistry ; Epitopes, T-Lymphocyte - immunology ; Fundamental and applied biological sciences. Psychology ; HIV Core Protein p24 - chemistry ; HIV Core Protein p24 - genetics ; HIV Core Protein p24 - immunology ; HIV Infections - immunology ; HIV Infections - virology ; HIV-1 - chemistry ; HIV-1 - genetics ; HIV-1 - immunology ; Human viral diseases ; Humans ; Infectious diseases ; Interferon-gamma - metabolism ; Lymphocyte Activation ; Medical sciences ; Microbiology ; Miscellaneous ; Molecular Sequence Data ; Peptides - chemistry ; Peptides - pharmacology ; Viral diseases ; Viral diseases of the lymphoid tissue and the blood. Aids ; Virology</subject><ispartof>AIDS research and human retroviruses, 2004-03, Vol.20 (3), p.315-325</ispartof><rights>2004 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c373t-3f4c5019309892cb55356596e06db421c484169507fc7c1f9b6537ce6fececc93</citedby><cites>FETCH-LOGICAL-c373t-3f4c5019309892cb55356596e06db421c484169507fc7c1f9b6537ce6fececc93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,3029,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=15610509$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15117455$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>NORRIS, Philip J</creatorcontrib><creatorcontrib>MOFFETT, Howell F</creatorcontrib><creatorcontrib>BRANDER, Christian</creatorcontrib><creatorcontrib>ALLEN, Todd M</creatorcontrib><creatorcontrib>O'SULLIVAN, Kristin M</creatorcontrib><creatorcontrib>COSIMI, Lisa A</creatorcontrib><creatorcontrib>KAUFMANN, Daniel E</creatorcontrib><creatorcontrib>WALKER, Bruce D</creatorcontrib><creatorcontrib>ROSENBERG, Eric S</creatorcontrib><title>Fine specificity and cross-clade reactivity of HIV type 1 gag-specific CD4+ T cells</title><title>AIDS research and human retroviruses</title><addtitle>AIDS Res Hum Retroviruses</addtitle><description>Despite growing evidence that HIV-1-specific CD4(+) T helper (Th) cells may play a role in the control of viremia, discrete Th cell epitopes remain poorly defined. Furthermore, it is not known whether Th cell responses generated using vaccines based on clade B virus sequences will elicit immune responses that are effective in regions of the world where non-clade B viruses predominate. To address these issues we isolated CD4(+) T cell clones from individuals with vigorous HIV-1-specific Th cell responses and identified the minimum epitopes recognized. The minimum peptide length required for induction of CD4(+) T cell proliferation, IFN-gamma secretion, and cytolytic activity ranged from 9 to 16 amino acids in the five epitopes studied. Cross-clade recognition of the defined epitopes was examined for variant peptides from clades A, B, C, D, and AE. Over half the variant epitopes (17 of 32) exhibited impaired recognition, defined as less than 50% of the IFN-gamma secretion elicited by B clade consensus sequence. There was no evidence for antagonistic activity mediated by the variant peptides, and despite strong responses there was no escape of autologous virus from Th responses in the epitopes we studied. Abrogated recognition of variant CD4(+) T cell epitopes presents a potential obstacle to vaccine development.</description><subject>AIDS/HIV</subject><subject>Amino Acid Sequence</subject><subject>Biological and medical sciences</subject><subject>CD4-Positive T-Lymphocytes - immunology</subject><subject>Clone Cells</subject><subject>Cross Reactions</subject><subject>Epitope Mapping</subject><subject>Epitopes, T-Lymphocyte - chemistry</subject><subject>Epitopes, T-Lymphocyte - immunology</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>HIV Core Protein p24 - chemistry</subject><subject>HIV Core Protein p24 - genetics</subject><subject>HIV Core Protein p24 - immunology</subject><subject>HIV Infections - immunology</subject><subject>HIV Infections - virology</subject><subject>HIV-1 - chemistry</subject><subject>HIV-1 - genetics</subject><subject>HIV-1 - immunology</subject><subject>Human viral diseases</subject><subject>Humans</subject><subject>Infectious diseases</subject><subject>Interferon-gamma - metabolism</subject><subject>Lymphocyte Activation</subject><subject>Medical sciences</subject><subject>Microbiology</subject><subject>Miscellaneous</subject><subject>Molecular Sequence Data</subject><subject>Peptides - chemistry</subject><subject>Peptides - pharmacology</subject><subject>Viral diseases</subject><subject>Viral diseases of the lymphoid tissue and the blood. Aids</subject><subject>Virology</subject><issn>0889-2229</issn><issn>1931-8405</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNplkDFPwzAUhC0EoqXwBxiQF1hQwI797HhEhVKkSgwU1sh5saugNClxitR_T0KDQGJ6w_vudHeEnHN2w1liblmSmDiOmRRxbIwCkAdkzI3gUSIZHJJxD0QdYUbkJIR3xljHwzEZceBcS4AxeZkVlaNh47DwBRbtjtoqp9jUIURY2tzRxllsi8_-VXs6f3qj7W7jKKcru4p-hHR6L6_pkqIry3BKjrwtgzsb7oS8zh6W03m0eH58mt4tIhRatJHwEoF1eZnpemAGIECBUY6pPJMxR5lIrgww7VEj9yZTIDQ65R06RCMm5Grvu2nqj60LbbouQp_AVq7ehlTzRBsNvAPjPfjdq3E-3TTF2ja7lLO0nzL9P2Unuhjct9na5b-SYbsOuBwAG9CWvrEVFuEPpzgDZsQX7154zQ</recordid><startdate>20040301</startdate><enddate>20040301</enddate><creator>NORRIS, Philip J</creator><creator>MOFFETT, Howell F</creator><creator>BRANDER, Christian</creator><creator>ALLEN, Todd M</creator><creator>O'SULLIVAN, Kristin M</creator><creator>COSIMI, Lisa A</creator><creator>KAUFMANN, Daniel E</creator><creator>WALKER, Bruce D</creator><creator>ROSENBERG, Eric S</creator><general>Liebert</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20040301</creationdate><title>Fine specificity and cross-clade reactivity of HIV type 1 gag-specific CD4+ T cells</title><author>NORRIS, Philip J ; MOFFETT, Howell F ; BRANDER, Christian ; ALLEN, Todd M ; O'SULLIVAN, Kristin M ; COSIMI, Lisa A ; KAUFMANN, Daniel E ; WALKER, Bruce D ; ROSENBERG, Eric S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c373t-3f4c5019309892cb55356596e06db421c484169507fc7c1f9b6537ce6fececc93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>AIDS/HIV</topic><topic>Amino Acid Sequence</topic><topic>Biological and medical sciences</topic><topic>CD4-Positive T-Lymphocytes - immunology</topic><topic>Clone Cells</topic><topic>Cross Reactions</topic><topic>Epitope Mapping</topic><topic>Epitopes, T-Lymphocyte - chemistry</topic><topic>Epitopes, T-Lymphocyte - immunology</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>HIV Core Protein p24 - chemistry</topic><topic>HIV Core Protein p24 - genetics</topic><topic>HIV Core Protein p24 - immunology</topic><topic>HIV Infections - immunology</topic><topic>HIV Infections - virology</topic><topic>HIV-1 - chemistry</topic><topic>HIV-1 - genetics</topic><topic>HIV-1 - immunology</topic><topic>Human viral diseases</topic><topic>Humans</topic><topic>Infectious diseases</topic><topic>Interferon-gamma - metabolism</topic><topic>Lymphocyte Activation</topic><topic>Medical sciences</topic><topic>Microbiology</topic><topic>Miscellaneous</topic><topic>Molecular Sequence Data</topic><topic>Peptides - chemistry</topic><topic>Peptides - pharmacology</topic><topic>Viral diseases</topic><topic>Viral diseases of the lymphoid tissue and the blood. Aids</topic><topic>Virology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>NORRIS, Philip J</creatorcontrib><creatorcontrib>MOFFETT, Howell F</creatorcontrib><creatorcontrib>BRANDER, Christian</creatorcontrib><creatorcontrib>ALLEN, Todd M</creatorcontrib><creatorcontrib>O'SULLIVAN, Kristin M</creatorcontrib><creatorcontrib>COSIMI, Lisa A</creatorcontrib><creatorcontrib>KAUFMANN, Daniel E</creatorcontrib><creatorcontrib>WALKER, Bruce D</creatorcontrib><creatorcontrib>ROSENBERG, Eric S</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>AIDS research and human retroviruses</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>NORRIS, Philip J</au><au>MOFFETT, Howell F</au><au>BRANDER, Christian</au><au>ALLEN, Todd M</au><au>O'SULLIVAN, Kristin M</au><au>COSIMI, Lisa A</au><au>KAUFMANN, Daniel E</au><au>WALKER, Bruce D</au><au>ROSENBERG, Eric S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Fine specificity and cross-clade reactivity of HIV type 1 gag-specific CD4+ T cells</atitle><jtitle>AIDS research and human retroviruses</jtitle><addtitle>AIDS Res Hum Retroviruses</addtitle><date>2004-03-01</date><risdate>2004</risdate><volume>20</volume><issue>3</issue><spage>315</spage><epage>325</epage><pages>315-325</pages><issn>0889-2229</issn><eissn>1931-8405</eissn><coden>ARHRE7</coden><abstract>Despite growing evidence that HIV-1-specific CD4(+) T helper (Th) cells may play a role in the control of viremia, discrete Th cell epitopes remain poorly defined. Furthermore, it is not known whether Th cell responses generated using vaccines based on clade B virus sequences will elicit immune responses that are effective in regions of the world where non-clade B viruses predominate. To address these issues we isolated CD4(+) T cell clones from individuals with vigorous HIV-1-specific Th cell responses and identified the minimum epitopes recognized. The minimum peptide length required for induction of CD4(+) T cell proliferation, IFN-gamma secretion, and cytolytic activity ranged from 9 to 16 amino acids in the five epitopes studied. Cross-clade recognition of the defined epitopes was examined for variant peptides from clades A, B, C, D, and AE. Over half the variant epitopes (17 of 32) exhibited impaired recognition, defined as less than 50% of the IFN-gamma secretion elicited by B clade consensus sequence. There was no evidence for antagonistic activity mediated by the variant peptides, and despite strong responses there was no escape of autologous virus from Th responses in the epitopes we studied. Abrogated recognition of variant CD4(+) T cell epitopes presents a potential obstacle to vaccine development.</abstract><cop>Larchmont, NY</cop><pub>Liebert</pub><pmid>15117455</pmid><doi>10.1089/088922204322996554</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0889-2229
ispartof AIDS research and human retroviruses, 2004-03, Vol.20 (3), p.315-325
issn 0889-2229
1931-8405
language eng
recordid cdi_proquest_miscellaneous_71879751
source Mary Ann Liebert Online Subscription; MEDLINE; Alma/SFX Local Collection
subjects AIDS/HIV
Amino Acid Sequence
Biological and medical sciences
CD4-Positive T-Lymphocytes - immunology
Clone Cells
Cross Reactions
Epitope Mapping
Epitopes, T-Lymphocyte - chemistry
Epitopes, T-Lymphocyte - immunology
Fundamental and applied biological sciences. Psychology
HIV Core Protein p24 - chemistry
HIV Core Protein p24 - genetics
HIV Core Protein p24 - immunology
HIV Infections - immunology
HIV Infections - virology
HIV-1 - chemistry
HIV-1 - genetics
HIV-1 - immunology
Human viral diseases
Humans
Infectious diseases
Interferon-gamma - metabolism
Lymphocyte Activation
Medical sciences
Microbiology
Miscellaneous
Molecular Sequence Data
Peptides - chemistry
Peptides - pharmacology
Viral diseases
Viral diseases of the lymphoid tissue and the blood. Aids
Virology
title Fine specificity and cross-clade reactivity of HIV type 1 gag-specific CD4+ T cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T09%3A14%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Fine%20specificity%20and%20cross-clade%20reactivity%20of%20HIV%20type%201%20gag-specific%20CD4+%20T%20cells&rft.jtitle=AIDS%20research%20and%20human%20retroviruses&rft.au=NORRIS,%20Philip%20J&rft.date=2004-03-01&rft.volume=20&rft.issue=3&rft.spage=315&rft.epage=325&rft.pages=315-325&rft.issn=0889-2229&rft.eissn=1931-8405&rft.coden=ARHRE7&rft_id=info:doi/10.1089/088922204322996554&rft_dat=%3Cproquest_cross%3E71879751%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71879751&rft_id=info:pmid/15117455&rfr_iscdi=true